Fairfield, Bush & Co’s Alcon CHF 0.20 PAR VALUE ACL Stock Holding History

Fairfield, Bush & Co’s Portfolio ACL Stock Details ACL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-12,127	Closed	-$686K	–	149
2019 Q4	$686K	Sell	12,127 -57	-0.5%	-$3.22K	0.25%	82
2019 Q3	$711K	Sell	12,184 -679	-5%	-$39.6K	0.25%	80
2019 Q2	$798K	Buy	+12,863	New	+$798K	0.27%	76

Other funds holding ACL

AMG

Advisors Management Group La Crosse, Wisconsin $549M AUM 29.35% 1-Year Est. Return

Fairfield, Bush & Co's ACL Position: Q1 2020 in Review

Fairfield, Bush & Co sold out of Alcon CHF 0.20 PAR VALUE (ACL) in Q1 2020, closing a stake of 12,127 shares — an estimated $686K sold.

Fairfield, Bush & Co first reported a position in ACL in Q2 2019 and held it in 3 quarters. The position peaked at $798K in Q2 2019. 2 funds tracked by Wall St. Rank hold ACL as of Q1 2020.

Fairfield, Bush & Co reported no remaining Alcon CHF 0.20 PAR VALUE position as of Q1 2020 after selling out during the quarter.
Fairfield, Bush & Co sold 12,127 Alcon CHF 0.20 PAR VALUE shares in Q1 2020, an estimated $686K.
Fairfield, Bush & Co first reported a position in Alcon CHF 0.20 PAR VALUE in Q2 2019 and held it in 3 quarters.
Fairfield, Bush & Co's Alcon CHF 0.20 PAR VALUE position peaked at $798K in Q2 2019.
2 funds tracked by Wall St. Rank held Alcon CHF 0.20 PAR VALUE as of Q1 2020.

Based on Fairfield, Bush & Co's 13F filing for Q1 2020, filed 13 May 2020.